Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
Background Liver cirrhotic patients with nonvalvular atrial fibrillation have been excluded from randomized clinical studies regarding oral anticoagulants for stroke prevention. Whether non–vitamin K antagonist oral anticoagulants (NOACs) are superior to warfarin for these patients remains unclear....
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Wiley
2019-03-01
|
| Serie: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Soggetti: | |
| Accesso online: | https://www.ahajournals.org/doi/10.1161/JAHA.118.011112 |